Current Pharmaceutical Design
Title:Corrigendum: The Role of Statins in the Treatment of Type 2 Diabetes Mellitus: An Update
Volume: 21 Issue: 24
Author(s): N. Katsiki, V.G. Athyros and A. Karagiannis
Affiliation:
Export Options
About this article
Cite this article as:
Katsiki N., Athyros V.G. and Karagiannis A., Corrigendum: The Role of Statins in the Treatment of Type 2 Diabetes Mellitus: An Update, Current Pharmaceutical Design 2015; 21 (24) . https://dx.doi.org/10.2174/138161282124150810154921
DOI https://dx.doi.org/10.2174/138161282124150810154921 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
29
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
TRAIL as Biomarker and Potential Therapeutic Tool for Cardiovascular Diseases
Current Drug Targets Sodium-glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis; from Pathophysiology to Clinical Practice
Cardiovascular & Hematological Disorders-Drug Targets A More Accurate Approach to Molecular Genetics Analysis in Vascular Disease
Cardiovascular & Hematological Disorders-Drug Targets Determination of Sitagliptin with Fluorescamine in Tablets and Spiked Serum Samples by Spectrofluorimetry and a Degradation Study
Current Pharmaceutical Analysis Re-Discovering PDE3 Inhibitors - New Opportunities for a Long Neglected Target
Current Topics in Medicinal Chemistry The Cardiovascular Effects of Metformin: Further Reasons to Consider An Old Drug as a Cornerstone in the Therapy of Type 2 Diabetes Mellitus
Current Vascular Pharmacology Anti-Insulin Receptor Antibodies in the Pathology and Therapy of Diabetes Mellitus
Current Diabetes Reviews Phenolic Compounds as Antioxidants: Carbonic Anhydrase Isoenzymes Inhibitors
Mini-Reviews in Medicinal Chemistry Micro-RNA in Disease and Gene Therapy
Current Drug Discovery Technologies New and Promising Chemotherapeutics for Emerging Infections Involving Drug-resistant Non-albicans Candida Species
Current Topics in Medicinal Chemistry Diabetic Retinopathy Screening by General Practitioners Using Non- Mydriatic Retinography
Current Diabetes Reviews Non-Alcoholic Fatty Liver Disease and Vascular Disease
Current Vascular Pharmacology Clinical Review: Safety and Efficacy Comparison between Sulfonylureas and Dipeptidyl Peptidase-4 Inhibitors as Second-Line Therapies in Type 2 Diabetes Mellitus
Current Pharmaceutical Design Interval Exercise Therapy for Type 2 Diabetes
Current Diabetes Reviews Melanocortin Receptors, Melanotropic Peptides and Penile Erection
Current Topics in Medicinal Chemistry Targeting Gender Difference in the Introduction of New Drugs for Diabetes Mellitus and Metabolic Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Medication-Induced Nephrotoxicity in Older Patients
Current Drug Metabolism BeMORE: A Novel Method for Detection of Adverse Fetal Effects Induced by Drugs
Current Drug Safety Ligand-receptor Engineering and its Application Towards the Complementation of Genetic Disease and Target Identification
Current Topics in Medicinal Chemistry Atherosclerosis and Inflammation: Insight from Carotid and Intracoronary Ultrasound Studies
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry